Keyphrases
Liver Transplantation
71%
Transplantation
65%
Ischemia-reperfusion Injury
43%
Kidney Transplantation
41%
Organ Transplantation
35%
Transplant Arteriosclerosis
31%
Solid Organ Transplantation
30%
Kidney Transplant Recipients
28%
Orthotopic Liver Transplantation
27%
Pediatric Liver Transplantation
25%
Human Regulatory T Cells
25%
Treg
24%
Nanotherapeutics
23%
Liver
22%
Endothelial Cells
22%
Renal Transplant Recipients
22%
COVID-19
21%
Acute Rejection
21%
Risk Factors
21%
Clinical Outcomes
21%
African American
21%
T Cells
21%
Brain Death
19%
Graft Loss
19%
Nanoparticles
18%
Complement Inhibitors
18%
Rapamycin
18%
Kidney Transplant
18%
Allogeneic
17%
Immunogenicity
16%
Heart Valve
16%
Lung Transplantation
16%
Allograft
16%
Regulatory T Cells
16%
Pretransplant
16%
Lung
14%
Kidney
14%
Humanized Mouse Model
14%
Readmission
14%
Transplant Recipients
14%
Pediatric Patients
14%
Graft Outcome
13%
Alloantigen
13%
Graft Survival
13%
Living Donor
12%
Donor Organs
12%
Immunosuppression
12%
Prospective Randomized Trial
12%
Randomized pilot Trial
12%
Pancreas Transplantation
12%
Medicine and Dentistry
Transplantation
100%
Liver Transplantation
80%
Kidney Graft
61%
Kidney Transplantation
43%
Pediatrics
37%
Allograft
32%
Ex Vivo
29%
T Cell
28%
Arteriosclerosis
26%
Human T Regulatory Cell
25%
Health Care Cost
25%
Surgery
23%
Graft Survival
23%
Liver Graft
22%
Organ Transplantation
21%
Pancreas Transplantation
20%
Graft Failure
20%
Rapamycin
18%
Injury
18%
Solid Organ Transplantation
17%
Lung
16%
Heart Valve
16%
Acute Graft Rejection
16%
Living Donors
15%
Pulmonary Fibrosis
14%
Delayed Graft Function
13%
Infection
13%
Complement Inhibitor
12%
Endothelial Cell
12%
Systemic Scleroderma
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Transplant Surgeon
12%
Graft Rejection
12%
Neoplasm
12%
End Stage Renal Disease
11%
Endoplasmic Reticulum Stress
10%
Vascularity
10%
Pediatrics Patient
10%
Peripheral Blood Mononuclear Cell
10%
Drug Therapy
10%
Cohort Analysis
10%
Inferior Vena Cava
10%
Diabetes Mellitus
10%
Cryopreservation
10%
Immunogenicity
9%
Immunosuppressive Drug
9%
Stenting
9%
Hepatic Portal Vein
9%
Chronic Graft Rejection
9%
Epstein Barr Virus
9%
Immunology and Microbiology
Reperfusion
44%
Allograft
42%
Regulatory T Cell
41%
T Cell
38%
Immunology
31%
Solid Organ Transplantation
28%
Transplant Rejection
25%
Human T Regulatory Cell
25%
Mouse Model
24%
Immunosuppressive Drug
22%
Immunosuppression
21%
Organ Transplantation
20%
Chronic Graft Rejection
20%
Alloantigen
19%
Kidney Transplantation
19%
Lung Transplantation
19%
Acute Graft Rejection
18%
Complement Inhibitor
18%
Liver Transplantation
18%
Sirolimus
18%
Immunogenicity
17%
Humanized Mouse
16%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Pancreas Transplantation
12%
Macrophage
12%
Opportunistic Infection
12%
Autoantibodies
11%
T-Helper Cell
11%
Endoplasmic Reticulum Stress
10%
CD25
10%
Immunocompetent Cell
10%
CD4
10%
Solution and Solubility
9%
Complement Activation
8%
Micelle
8%
Proinflammatory Cytokine
8%
Perfusion
8%
Peripheral Blood Mononuclear Cell
7%
Autophagy
7%
Regulatory Cell
7%
Immunoglobulin G
7%
Cold Ischemia
7%
Transplantation Tolerance
6%
Cytomegalovirus
6%
Transplantation Research
6%
Immune Privilege
6%
Heart Valve
6%
Mediator
6%
Myeloid-Derived Suppressor Cell
6%
Cell Function
6%